New Research Highlights Gaps in How Investors Assess Rare-Disease Opportunities

Pixelgen Technologies raises $15.5M in oversubscribed Series B to accelerate global expansion and unlock new insights into biology

Guard Therapeutics completes reverse takeover of Disruptive Pharma

Enginio raises SEK 30 million from Industrifonden and leading retail profiles to accelerate growth

Evam raises SEK 38 million from Industrifonden and FSG to build the next generation public safety platform

Three questions to Elaine Jones, new Chair of BOOST Pharma

Three questions to Hans Schambye, new CEO of BOOST Pharma

Nayanika Bhalla, PhD has joined Industrifonden as an Associate on our Deep Tech team

Swedish Deep Tech Landscape 2025 – A Value Creation Roadmap for Deep Tech Companies